(ENTA) Enanta Pharmaceuticals - Performance -58.3% in 12m
Compare ENTA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-87.46%
#157 in Group
Rel. Strength
8.62%
#7271 in Universe
Total Return 12m
-58.31%
#122 in Group
Total Return 5y
-89.75%
#109 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: ENTA (-58.3%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ENTA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ENTA
| Total Return (including Dividends) | ENTA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 19.28% | 11.81% | 13.81% |
| 3 Months | 8.57% | -13.61% | -6.30% |
| 12 Months | -58.31% | -12.29% | 10.65% |
| 5 Years | -89.75% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | ENTA | XBI | S&P 500 |
| 1 Month | 57.0% | 72.9% | 83% |
| 3 Months | -60.6% | -83% | -75.3% |
| 12 Months | -87.9% | -51.6% | 50.1% |
| 5 Years | -76.7% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #71 | 6.69% | 4.81% |
| 3 Month | #26 | 25.7% | 15.9% |
| 12 Month | #121 | -52.5% | -62.3% |
| 5 Years | #110 | -86.4% | -95.1% |
FAQs
Does ENTA Enanta Pharmaceuticals outperforms the market?
No,
over the last 12 months ENTA made -58.31%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months ENTA made 8.57%, while XBI made -13.61%.
Over the last 3 months ENTA made 8.57%, while XBI made -13.61%.
Performance Comparison ENTA vs Indeces and Sectors
ENTA vs. Indices ENTA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -13.3% | 5.47% | -47.0% | -69.0% |
| US NASDAQ 100 | QQQ | -13.4% | 1.92% | -47.2% | -70.0% |
| US Dow Jones Industrial 30 | DIA | -13.7% | 9.29% | -46.7% | -66.0% |
| German DAX 40 | DAX | -13.2% | 4.32% | -73.3% | -84.0% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -15.4% | 7.45% | -47.8% | -65.7% |
| Hongkong Hang Seng | HSI | -16.4% | -0.65% | -55.4% | -72.0% |
| India NIFTY 50 | INDA | -8.33% | 14.4% | -47.4% | -58.1% |
| Brasil Bovespa | EWZ | -14.3% | 2.04% | -55.7% | -50.0% |
ENTA vs. Sectors ENTA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -13.9% | 5.87% | -54.1% | -79.9% |
| Consumer Discretionary | XLY | -13.6% | 5.05% | -46.0% | -72.6% |
| Consumer Staples | XLP | -12.4% | 12.7% | -53.9% | -67.4% |
| Energy | XLE | -13.1% | 12.5% | -40.4% | -48.9% |
| Financial | XLF | -14.4% | 5.76% | -54.1% | -80.7% |
| Health Care | XLV | -10.2% | 18.4% | -42.0% | -54.3% |
| Industrial | XLI | -14.9% | 2.46% | -48.4% | -69.3% |
| Materials | XLB | -13.1% | 5.72% | -42.1% | -53.1% |
| Real Estate | XLRE | -11.9% | 7.74% | -47.8% | -73.8% |
| Technology | XLK | -14.3% | -1.94% | -44.1% | -65.4% |
| Utilities | XLU | -13.3% | 9.69% | -54.7% | -75.8% |
| Aerospace & Defense | XAR | -15.2% | -1.88% | -58.5% | -85.6% |
| Biotech | XBI | -6.66% | 7.47% | -26.9% | -46.0% |
| Homebuilder | XHB | -13.7% | 7.80% | -33.8% | -50.8% |
| Retail | XRT | -15.2% | 4.63% | -42.8% | -56.8% |